Liver injury in coronavirus disease 2019
10.3969/j.issn.1001-5256.2020.05.011
- VernacularTitle:新型冠状病毒肺炎的肝损伤
- Author:
Shujie LAI
1
;
Hongli CUI
;
Dongfeng CHEN
Author Information
1. Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing 400042, China
- Publication Type:Research Article
- Keywords:
2019 novel coronavirus;
hepatic insufficiency;
cytokine-induced killer cells
- From:
Journal of Clinical Hepatology
2020;36(5):1004-1007
- CountryChina
- Language:Chinese
-
Abstract:
At present, coronavirus disease 2019 (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) infection has spread rapidly in China and more than 70 countries around the world and thus become a public health event of international concern. In addition to fever and respiratory symptoms, varying degrees of liver injury is also observed after 2019-nCoV infection. This article reviews the clinical features, pathology, pathogenic mechanism, and therapeutic strategies of liver injury associated with COVID-19, hoping to provide a reference for clinical decision-making on the prevention and treatment of COVID-19.
